Michael Sherman's most recent trade in Werewolf Therapeutics Inc was a trade of 27,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Michael A. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 1,150,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 875,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 700,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 632,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 557,050 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 233,413 | 0 (0%) | 0% | 8.5 | 1,995,681 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 102,995 | 0 (0%) | 0% | 8.5 | 880,607 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 87,000 | 0 (0%) | 0% | 8.6 | 743,850 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ontrak Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 91,829 | 91,829 | - | - | Option (right to buy) | |
| BioVie Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 56,900 | 56,900 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 23,325 | 23,325 | - | - | Stock Option (right to buy) | |
| Ontrak Inc | Michael E. Sherman | Director | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 20 Nov 2024 | 173 | 0 (0%) | 0% | 1.8 | 306 | Common Stock |
| Ontrak Inc | Michael E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 4,166,667 | 4,166,667 | - | - | Option (right to buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| TC Bancshares Inc | Michael Sherman Penney | EVP-CHIEF CREDIT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 10,000 | 10,000 | - | - | Employee Stock Option | |
| Werewolf Therapeutics Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 332,333 | 332,333 | - | - | Option (right to buy) | |
| TC Bancshares Inc | Michael Sherman Penney | EVP-CHIEF CREDIT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.99 per share. | 21 Dec 2023 | 390 | 7,662 | - | 14.0 | 5,456 | Common Stock |
| BioVie Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 89,750 | 89,750 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 12 May 2023 | 75,015 | 87,000 (0%) | 0% | 1.1 | 84,122 | Common Stock |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 12 May 2023 | 11,985 | 11,985 (0%) | 0% | 1.1 | 13,530 | Common Stock |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 557,050 | 557,050 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 92,950 | 222,995 (0%) | 0% | 0 | Common Stock | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 321,345 | 321,345 | - | - | Option (right to buy) | |
| TC Bancshares Inc | Sherman Penney Michael | EVP-CHIEF CREDIT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 15,000 | 15,000 | - | - | Employee Stock Option | |
| TC Bancshares Inc | Michael Penney Sherman | EVP-CHIEF CREDIT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 8,000 | 8,500 | - | 0 | Common Stock | |
| TC Bancshares Inc | Michael Sherman Penney | EVP-CHIEF CREDIT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. | 21 Dec 2022 | 448 | 8,052 | - | 14.9 | 6,653 | Common Stock |
| BioVie Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 75,000 | 75,000 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 460,759 | 460,759 | - | - | Restricted Stock Unit | |
| Ontrak Inc | Michael Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2022 | 61,040 | 0 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 61,040 | 61,040 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2022 | 56,299 | 0 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 56,299 | 56,299 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2022 | 37,794 | 0 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 37,794 | 37,794 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2022 | 16,630 | 0 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 16,630 | 16,630 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Aug 2022 | 5,010 | 0 | - | - | Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 5,010 | 5,010 | - | - | Option (right to buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. | 25 Jul 2022 | 100,000 | 125,364 (0%) | 0% | 2.1 | 209,000 | Common Stock |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 100,000 | 1,150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,600 | 11,600 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 130,150 | 130,150 | - | - | Stock Option (Right to buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 875,000 | 875,000 | - | - | Stock Option (Right to Buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 56,299 | 56,299 | - | - | Option (right to buy) | |
| Werewolf Therapeutics Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 23,200 | 23,200 | - | - | Stock Option (right to buy) | |
| Ontrak Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 5,010 | 5,010 | - | - | Option (right to buy) | |
| Chimerix Inc | Michael Sherman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| BioVie Inc | Michael Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 800 | 16,806 | - | - | options |